The impact of nodal isolated tumor cells on survival of breast cancer patients

American Journal of Surgery

Volumn 193, Issue 5 SPEC. ISS., 2007, Pages 571-574

  Herbert, Garth S ^a   Sohn, Vance Y ^a   Brown, Tommy A ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Immunohistochemistry; Isolated tumor cells; Prognosis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CELL ISOLATION; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 34147105903     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.01.007     Document Type: Article

References (18)

1. Fisher E.R., Fisher B., Sass R., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol No. 4). XI. Bilateral breast cancer. Cancer 54 (1984) 3002-3011
2. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
3. Coombes R.C., Berger U., Mansi J., et al. Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer. NCI Monogr 1 (1986) 51-53
4. Susnik B., Frkovic-Grazio S., and Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up. Ann Surg Oncol 11 (2004) 568-572
5. Cummings M.C., Walsh M.D., Hohn B.G., et al. Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol 26 (2002) 1286-1295
6. Millis R.R., Springall R., Lee A.H., et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer 86 (2002) 396-401
7. Elson C.E., Kufe D., and Johnston W.W. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases. Anal Quant Cytol Histol 15 (1993) 171-178
8. Dowlatshahi K., Fan M., Bloom K.J., et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 86 (1999) 990-996
9. Czerniecki B.J., Scheff A.M., Callans L.S., et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85 (1999) 1098-1103
10. Klein C.A., Blankenstein T.J., Schmidt-Kittler O., et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360 (2002) 683-689
11. Krauth J.S., Charitansky H., Isaac S., et al. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer. Eur J Surg Oncol 32 (2006) 400-404
12. Carter C.L., Allen C., and Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
13. Page D.L., Jensen R.A., and Simpson J.F. Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51 (1998) 195-208
14. Rosen P.R., Groshen S., Saigo P.E., et al. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7 (1989) 355-366
15. Lilleng P.K., and Hartveit F. 'Missed' micrometastases-the extent of the problem. Acta Oncol 39 (2000) 313-317
16. Joensuu H., Pylkkanen L., and Toikkanen S. Late mortality from pT1N0M0 breast carcinoma. Cancer 85 (1999) 2183-2189
17. Lundin J., Lundin M., Holli K., et al. Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study. J Clin Oncol 19 (2001) 28-36
18. Cote R.J., Peterson H.F., Chaiwun B., et al., International Breast Cancer Study Group. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 354 (1999) 896-900